Drug Profile
Research programme: autoimmune disease therapeutics - Alligator Bioscience
Latest Information Update: 14 Jan 2014
Price :
$50
*
At a glance
- Originator Alligator Bioscience; Unknown
- Class Antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Autoimmune disorders
Most Recent Events
- 14 Jan 2014 No development reported for Autoimmune disorders in Sweden (Parenteral)
- 26 Mar 2010 Early research in Autoimmune disorders in Sweden (unspecified route)